JOIN A CLINICAL STUDY

Are you interested in Accelerated TMS at Acacia?

We are conducting a research study, sponsored by Biomedical Discoveries and Neuroscientific Foundations (BDNF), to evaluate causal factors that affect accelerated TMS efficacy. We will study factors including treatment parameters, individual characteristics such as symptom profile and treatment history, subjective changes in mood, and medication use.

Get Started

ABOUT THE STUDY

Through this study, we aim to uncover the key factors that drive successful outcomes with TMS.

We will examine how different aspects of treatment influence both its overall effectiveness and long-term impact, with the goal of advancing more effective and personalized care.

By tracking how people feel after treatment, we hope to better understand when additional sessions may be beneficial and support long-term improvement.

MAIN ELIGIBILITY CRITERIA

Joining a clinical trial is an important and personal decision. Thank you for considering this study.

This study may be a good fit for individuals who meet the following criteria:

Are 12 years of age or older
Have been prescribed accelerated TMS by their doctor for treatment of a qualifying condition (e.g., Major Depressive Disorder, Generalized Anxiety Disorder, Alzheimer’s disease, Insomnia, Obsessive Compulsive Disorder, Bipolar Disorder, or Parkinson’s Disease)
Are able to communicate in English

Are able to complete follow-up questionnaires

There may be other requirements for participation in the study. The study doctor will explain these to you.

Condition

Depression, Anxiety

Age

12 years of age or older

Diagnosis

Major Depressive Disorder, Generalized Anxiety Disorder, Alzheimer’s disease, Insomnia, Obsessive Compulsive Disorder, Bipolar Disorder, or Parkinson’s Disease

WHAT TO EXPECT

If you choose to take part in the study, you will be asked to complete brief surveys about your mood and any symptoms you may be experiencing, such as depression or anxiety before, during, and after your TMS treatment.

Length of study: You may be asked to complete follow-up surveys for up to one year after treatment.
Study visits: Treatment involves one in-person visit. Follow-up surveys or visits with your doctor can be completed remotely.

Length of Study

The day you start treatment until one year after your final treatment.

Number of Study Visits

One in-person visit with follow-up surveys and visits completed remotely.

WHY PARTICIPATE

By joining this study, you can:

Contribute to cutting-edge research aimed at improving treatments for psychiatric and neurological conditions.
Monitor your symptoms over time, which may help identify early signs that additional TMS sessions could be beneficial.